Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Holdings
Ownership


All
13F
13D/G
Other
Tags
CC transcript
WuXi PharmaTech (Cayman) Inc. (WX) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/31/2017 CT ORDER Form CT ORDER - Confidential treatment order:
05/01/2017 CT ORDER Form CT ORDER - Confidential treatment order
02/10/2016 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
01/11/2016 SC 13G/A WELLINGTON MANAGEMENT GROUP LLP reports a 0% stake in WuXi PharmaTech Inc.
12/10/2015 SC 13E3/A Form SC 13E3/A - Going private transaction by certain issuers: [Amend]
12/10/2015 SC 13G/A WELLINGTON MANAGEMENT GROUP LLP reports a 5.7% stake in WuXi PharmaTech Inc.
11/20/2015 SC 13E3/A Form SC 13E3/A - Going private transaction by certain issuers: [Amend]
10/20/2015 SC 13E3/A Form SC 13E3/A - Going private transaction by certain issuers: [Amend]
10/09/2015 SC 13E3/A Form SC 13E3/A - Going private transaction by certain issuers: [Amend]
10/02/2015 SC 13G/A FIL Ltd reports a 4.8% stake in WUXI PHARMATECH CAYMAN INC
09/23/2015 SC 13E3/A Form SC 13E3/A - Going private transaction by certain issuers: [Amend]
09/01/2015 SC 13E3 Form SC 13E3 - Going private transaction by certain issuers:
04/15/2015 20-F Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
04/10/2015 SC 13G/A WELLINGTON MANAGEMENT GROUP LLP reports a 11.5% stake in WuXi PharmaTech Inc.
02/13/2015 SC 13G/A FIL Ltd reports a 10% stake in WUXI PHARMATECH CAYMAN INC
02/13/2015 SC 13G/A SCHRODER INVESTMENT MANAGEMENT NORTH AMERICA INC/ DE reports a 9.2% stake in WuXi PharmaTech Inc.
02/12/2015 SC 13G WELLINGTON MANAGEMENT GROUP LLP reports a 7.6% stake in WuXi PharmaTech Inc.
06/10/2014 SC 13G FIL Ltd reports a 5.4% stake in WUXI PHARMATECH CAYMAN INC
06/10/2014 SC 13G/A FMR LLC reports a 4.4% stake in WUXI PHARMATECH CAYMAN INC
04/15/2014 20-F Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
02/14/2014 SC 13G/A FMR LLC reports a 10.7% stake in WuXi PharmaTech Inc
02/12/2014 SC 13G COMMONWEALTH BANK OF AUSTRALIA reports a 4.6% stake in WuXi PharmaTech Inc.
02/12/2014 SC 13G SCHRODER INVESTMENT MANAGEMENT NORTH AMERICA INC/ DE reports a 7.2% stake in WuXi PharmaTech Inc
11/08/2013 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
08/13/2013 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
04/17/2013 20-F Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
02/14/2013 SC 13G COMMONWEALTH BANK OF AUSTRALIA reports a 6.1% stake in WuXi PharmaTech Inc.
02/14/2013 SC 13G/A FMR LLC reports a 14.6% stake in WuXi PharmaTech Inc
01/23/2013 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
11/14/2012 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
11/07/2012 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
10/09/2012 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
08/14/2012 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
07/30/2012 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy